Hangzhou Haoyue Personal Care Co Ltd (605009) fair value: what the stock is really worth
As of Sep 23, 2026: fair value of Hangzhou Haoyue Personal Care Co Ltd ¥22.66, price ¥24.82, upside -8.7%, quality 57 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Hangzhou Haoyue Personal Care Co Ltd for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.
How to read this chart
60‑month range ¥20.93 – ¥65.34 · fair‑value band ¥17.00 – ¥28.33 · the ¥24.82 price screens above the ¥22.66 fair value. Dashed = 300-day average. As of Sep 23, 2026.
Follow Hangzhou Haoyue Personal Care Co in your weekly email
Every Wednesday you see whether Hangzhou Haoyue Personal Care Co is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Hangzhou Haoyue Personal Care Co., Ltd. research, develops, manufactures, and sells women, young, and adult health care products under the haoyue brand name in China. The company sells baby diapers, including tape, and pull-up diaper, and wet tissue; adult diapers; nursing pad; and sanitary napkins products. Hangzhou Haoyue Personal Care Co., Ltd.
Show more
Hangzhou Haoyue Personal Care Co., Ltd. research, develops, manufactures, and sells women, young, and adult health care products under the haoyue brand name in China. The company sells baby diapers, including tape, and pull-up diaper, and wet tissue; adult diapers; nursing pad; and sanitary napkins products. Hangzhou Haoyue Personal Care Co., Ltd. was founded in 1992 and is headquartered in Hangzhou, China.
Stock analysis
Hangzhou Haoyue Personal Care Co Ltd (605009) currently trades at ¥24.82, while our model-based Fair Value estimate is ¥22.66, implying the stock looks roughly 9.5% fairly valued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ¥25.75 per share, and 3 of the 16 models we run sit above the ¥24.82 price.
Bear case: the Dividend Discount group reads lowest at ¥9.57, and 13 of the 16 models stay below the price. Evidence for this calculation is high.
Scenario range: ¥17.00 (bear) to ¥28.33 (bull), the price of ¥24.82 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 57/100 (solid quality), in the Consumer Defensive sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Hangzhou Haoyue Personal Care Co Ltd reported revenue of 3.8B CNY in FY2025 versus 2.5B CNY in FY2021, a compound +11.1%/yr. Reported net income was 232M CNY in FY2025, compounding −10.6%/yr from FY2021.
Key figures
Market cap 5.3B CNY (≈ $797M) · P/E ratio 23.6 · P/S ratio 1.46 · EPS (TTM) ¥1.05 · Dividend yield 3.4% · Net margin 6.2% · Return on equity 6.5% · Return on assets (EBIT) 9.5%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 42 out of 100 (medium confidence).
What moves the price
The share trades about 26% below its 52-week high and 18% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Consumer Defensive peers we cover trades at −25% fair-value upside, at −9%, 605009 screens cheaper than that median.
Fair Value models
Bear ¥17.00Fair Value ¥22.66Bull ¥28.33
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (¥0.1463 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.43/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+28.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.3%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.7%
Start year 2020 (pandemic)
Revenue growth 9 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+26.1%
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: EBIT basis.
−5.1%
Earnings growth per share plus dividend.
Earnings per share, growth per year−8.5%
Dividend (yield on the price)3.4%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−11% vs 18%, slowing
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.27% → 8%
Compare Hangzhou Haoyue Personal Care Co Ltd with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Household & Personal Products · 246 stocks
Beats the industry median on 4/13 measures
Overall it trails its industry peers.
Valuation
Quality Score57 · Below median
Fair Value upside−9% · Below median
Profitability
Return on equity (TTM)7% · Below median
Return on assets3% · Below median
Net margin (TTM)6% · Above median
Operating margin (TTM)11% · Above median
Growth and dividend
Revenue growth7% · Above median
Dividend yield (TTM)3.4% · Above median
Balance sheet
Debt / equity0.07× · Above median
Valuation Multiplesvs Household & Personal Products median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Hangzhou Haoyue Personal Care Co Ltd Fair Value". https://www.fairvalue-calculator.com/stock/605009
Frequently asked questions
Is Hangzhou Haoyue Personal Care Co Ltd (605009) overvalued or undervalued?
As of Sep 23, 2026, our model estimates a fair value of ¥22.66 versus a price of ¥24.82, about −9% upside (fairly valued).
What is the fair value of 605009?
Our model-based fair value for Hangzhou Haoyue Personal Care Co Ltd is ¥22.66 (as of Sep 23, 2026), built from audited fundamentals. The current price: ¥24.82.
What is the quality score of 605009?
Hangzhou Haoyue Personal Care Co Ltd has a Quality Score of 57/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Hangzhou Haoyue Personal Care Co Ltd (605009)?
Our model-based price target is the fair value of ¥22.66 (as of Sep 23, 2026) from 16 valuation models. Cautious scenario ¥17.00, optimistic scenario ¥28.33. It is a calculation from audited fundamentals, not an analyst target.
What is the Hangzhou Haoyue Personal Care Co Ltd stock forecast for 2026?
Our models put fair value at ¥22.66, about −9% upside versus a price of ¥24.82 (fairly valued). Cautious scenario ¥17.00, optimistic scenario ¥28.33. The calculation is refreshed regularly with new filings.
What is the revenue of Hangzhou Haoyue Personal Care Co Ltd (605009)?
Hangzhou Haoyue Personal Care Co Ltd reported trailing-twelve-month revenue of about 3.8B CNY (latest available figure, as of Sep 23, 2026).
Does Hangzhou Haoyue Personal Care Co Ltd pay a dividend?
Hangzhou Haoyue Personal Care Co Ltd currently shows a dividend yield of about 3.42% relative to its recent price (as of Sep 23, 2026).
What is the intrinsic value of Hangzhou Haoyue Personal Care Co Ltd (605009)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Hangzhou Haoyue Personal Care Co Ltd it is ¥22.66 per share (as of Sep 23, 2026), against a price of ¥24.82. It is the blended result of 16 valuation models (cash flow, earnings, asset, dividend).
Is Hangzhou Haoyue Personal Care Co Ltd stock overvalued or undervalued in 2026?
As of Sep 23, 2026, 605009 trades above its calculated fair value: price ¥24.82, fair value ¥22.66, a gap of about −9% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 605009?
No. The price is what the market pays today (¥24.82); the fair value is what the company's own numbers justify (¥22.66). For Hangzhou Haoyue Personal Care Co Ltd the two are ¥2.16 per share apart. That gap is exactly why we show both numbers side by side.
How much is Hangzhou Haoyue Personal Care Co Ltd worth?
The market values Hangzhou Haoyue Personal Care Co Ltd at about 5.3B CNY (market capitalisation, as of Sep 23, 2026). Per share that is ¥24.82; our models calculate a fair value of ¥22.66 per share.
What do the bullish and bearish scenarios say about 605009?
Our models span a range for Hangzhou Haoyue Personal Care Co Ltd: cautious scenario ¥17.00, base ¥22.66, optimistic ¥28.33 per share (as of Sep 23, 2026, price ¥24.82). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 605009?
Hangzhou Haoyue Personal Care Co Ltd trades at a price-to-earnings ratio of 23.6 (as of Sep 23, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ¥22.66 is built from several models across several years. Other multiples: P/B 1.6, P/S 1.4, EV/EBITDA 11.5.
How solid is the balance sheet of Hangzhou Haoyue Personal Care Co Ltd (605009)?
Balance-sheet figures for Hangzhou Haoyue Personal Care Co Ltd (as of Sep 23, 2026): return on equity 6.5%, debt of 0.07 per unit of equity. They feed the Quality Score of 57/100, which measures business quality independently of the share price.
How far is 605009 from its 52-week high?
Hangzhou Haoyue Personal Care Co Ltd trades at ¥24.82, about 26% below its 52-week high of ¥33.67 and 18% above the low of ¥20.99 (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of ¥22.66 is for.
Which stocks are comparable to Hangzhou Haoyue Personal Care Co Ltd?
From the same area (Consumer Defensive) we also value The Procter & Gamble Company, Colgate-Palmolive Company, Hindustan Unilever Limited, Kenvue Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Hangzhou Haoyue Personal Care Co Ltd stock attractive at the current price?
The data as of Sep 23, 2026: price ¥24.82, calculated fair value ¥22.66 (−9%), Quality Score 57/100, from 16 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 605009 calculated?
We run Hangzhou Haoyue Personal Care Co Ltd through 16 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ¥22.66, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. Hangzhou Haoyue Personal Care Co Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Hangzhou Haoyue Personal Care Co Ltd (605009)?
The closing price on Sep 23, 2026 was ¥24.82. Our model-based fair value is ¥22.66, about −9% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Hangzhou Haoyue Personal Care Co Ltd right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. The price sits in the upper half of our model range, so the margin of safety is thin. The data supports the verdict: every model runs on fully documented inputs.
Key figures of Hangzhou Haoyue Personal Care Co Ltd
How large is the market capitalisation of Hangzhou Haoyue Personal Care Co Ltd (605009)?
The market capitalisation of Hangzhou Haoyue Personal Care Co Ltd is 5.3B CNY (≈ $797M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Hangzhou Haoyue Personal Care Co Ltd (605009)?
The price-to-sales ratio of Hangzhou Haoyue Personal Care Co Ltd is 1.46 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Hangzhou Haoyue Personal Care Co Ltd (605009)?
Earnings per share at Hangzhou Haoyue Personal Care Co Ltd are ¥1.05 (price ÷ EPS = P/E 23.6). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Hangzhou Haoyue Personal Care Co Ltd (605009)?
The dividend yield of Hangzhou Haoyue Personal Care Co Ltd is 3.4% (payout 81.0%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Hangzhou Haoyue Personal Care Co Ltd (605009)?
The net margin of Hangzhou Haoyue Personal Care Co Ltd is 6.2% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Hangzhou Haoyue Personal Care Co Ltd (605009)?
The return on equity (ROE) of Hangzhou Haoyue Personal Care Co Ltd is 6.5% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Hangzhou Haoyue Personal Care Co Ltd (605009)?
On an EBIT basis the return on assets of Hangzhou Haoyue Personal Care Co Ltd is 9.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Hangzhou Haoyue Personal Care Co Ltd (605009)?
The operating margin of Hangzhou Haoyue Personal Care Co Ltd is 11.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Hangzhou Haoyue Personal Care Co Ltd (605009)?
Revenue at Hangzhou Haoyue Personal Care Co Ltd is growing +7.0% versus a year earlier (3y avg +10.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Hangzhou Haoyue Personal Care Co Ltd (605009)?
Earnings per share at Hangzhou Haoyue Personal Care Co Ltd are growing −7.1% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Hangzhou Haoyue Personal Care Co Ltd (605009) generate?
The free cash flow of Hangzhou Haoyue Personal Care Co Ltd is −325M CNY (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Hangzhou Haoyue Personal Care Co Ltd (605009) hold?
Hangzhou Haoyue Personal Care Co Ltd holds more cash than debt, 1.0B CNY net (fiscal year 2024). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Hangzhou Haoyue Personal Care Co Ltd in the live analysis
One click puts Hangzhou Haoyue Personal Care Co Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
